Meta-analysis of microarray data: the case of imatinib resistance in chronic myelogenous leukemia
DOI10.1016/J.COMPBIOLCHEM.2010.06.003zbMATH Open1365.92061OpenAlexW1991011835WikidataQ33629670 ScholiaQ33629670MaRDI QIDQ2359331FDOQ2359331
Francisco J. Burguillo, J. Martin, Inmaculada Barrera, W. G. Bardsley
Publication date: 28 June 2017
Published in: Computational Biology and Chemistry (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/j.compbiolchem.2010.06.003
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50) Biochemistry, molecular biology (92C40) Genetics and epigenetics (92D10)
Cites Work
Uses Software
Recommendations
- Imputation of truncated \(p\)-values for meta-analysis methods and its genomic application π π
- Cross-study validation and combined analysis of gene expression microarray data π π
- Meta-analysis for ranked discovery datasets: theoretical framework and empirical demonstration for microarrays π π
- Combining Results of Microarray Experiments: A Rank Aggregation Approach π π
- An empirical Bayes' approach to joint analysis of multiple microarray gene expression studies π π
This page was built for publication: Meta-analysis of microarray data: the case of imatinib resistance in chronic myelogenous leukemia
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q2359331)